Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Eagle Pharmaceutical (EGRX)

65.84 -0.69 (-1.04%)

05-23 16:00

Open:

65.94

Pre. Close:

66.53

High:

67.2236

Low:

65.63

Volume:

149,964

Market Cap:

977M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

67.305 - 67.632

67.632 - 67.955

Low:

64.665 - 65.076

65.076 - 65.481

Close:

65.081 - 65.731

65.731 - 66.371

Technical analysis  (as of: 2018-05-23 4:26:54 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 81.16     One year: 94.80

Support:

Support1: 58.49    Support2: 51.69

Resistance:

Resistance1: 69.49    Resistance2: 81.16

Pivot:

62.69

Moving Averages:

MA(5): 66.16     MA(20): 60.23

MA(100): 57.65     MA(250): 59.66

MACD:

MACD(12,26): 3.27     Signal(12,26,9): 2.80

%K %D:

%K(14,3): 78.10     %D(3): 78.84

RSI:

RSI(14): 64.56

52-Week:

High: 84.2  Low: 45.05  Change(%): -10.9

Average Vol(K):

3-Month: 23240  10-Days 34339

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
EGRX has closed below upper band by 33.2%. Bollinger Bands are 106.8% wider than normal. The large width of the bands suggest high volatility as compared to EGRX's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

2018-05-18T08:00:00-04:00
3 Things In Biotech, May 17: Insmed's Approval Chance, Pfizer Finally Proves Similar, Eagle Ascends

2018-05-16T07:46:28-04:00
FDA approves Eagle Pharmaceuticals' RTD HCI solution in a 500ml admixture

2018-05-16T06:50:00-04:00
Eagle Pharmaceuticals, Inc. Granted Final FDA Approval for Bendamustine Hydrochloride Ready-to-Dilute Solution in a 500ml Admixture

2018-05-10T13:47:05-04:00
Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2018 Results - Earnings Call Transcript

2018-05-10T06:52:40-04:00
Eagle Pharmaceuticals misses by $0.14, misses on revenue

2018-05-10T06:50:00-04:00
Eagle Pharmaceuticals, Inc. Reports First Quarter 2018 Results

2018-05-09T17:30:14-04:00
Notable earnings before Thursday's open

2018-05-07T13:37:33-04:00
Valuation Dashboard: Healthcare - Update

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

14.83

Shares Float (M)

13.31

% Held by Insiders

10.20

% Held by Institutions

Shares Short (K)

2882

Shares Short Prior Month (K)

3890

Stock Financials

EPS

2.410

EPS Est. Current Year

3.790

EPS Est. Next Year

4.400

EPS Est. Next Quarter

1.050

Forward EPS

4.181

Book Value (p.s.)

5.160

PEG Ratio

0.94

Profit Margin

18.15

Operating Margin

31.89

Return on Assets (ttm)

21.5

Return on Equity (ttm)

31.5

Qtrly Rev. Growth

-42.3

Gross Profit (p.s.)

5.911

Sales Per Share

EBITDA (p.s.)

2.211

Qtrly Earnings Growth

-84.10

Operating Cash Flow (M)

58.92

Levered Free Cash Flow (M)

44.40

atoplab.com

Valuation

P/E

27.32

P/E Growth Ratio

-0.01

P/BV

12.76

P/S

62352616.00

P/CF

16.57

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.